|
|
|||||||||||
The British Journal of Psychiatry 149: 654-656 (1986)
© 1986 The Royal College of Psychiatrists
MF Ford
Depression is common in Huntington's disease. It is customary to treat such patients with tricyclic antidepressants, although there is disagreement about their effectiveness. The use of monomine oxidase inhibitors for depression in HD has not previously been reported; three cases are described here. MAOIs appear to be of value in the management of depression in HD.
This article has been cited by other articles:
![]() |
A R. o. t. ANPA Committee on Research, E. C. Lauterbach, J. L. Cummings, J. Duffy, C. E. Coffey, D. Kaufer, M. Lovell, P. Malloy, A. Reeve, D. R. Royall, et al. Neuropsychiatric Correlates and Treatment of Lenticulostriatal Diseases: A Review of the Literature and Overview of Research Opportunities in Huntington's, Wilson's, and Fahr's Diseases J Neuropsychiatry Clin Neurosci, August 1, 1998; 10(3): 249 - 266. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |